FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Metro Brands IPO and Supriya Lifescience IPO.
Metro Brands IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Supriya Lifescience IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Metro Brands IPO | Supriya Lifescience IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Ambit Private Limited Axis Capital Limited Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Equirus Capital Private Limited ICICI Securities Limited Motilal Oswal Investment Advisors Limited |
Axis Capital Limited ICICI Securities Limited |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Metro Brands IPO is up to ₹1,367.51 Cr whereas the issue size of the Supriya Lifescience IPO is up to ₹700.00 Cr. The final issue price of Metro Brands IPO is ₹500.00 per share and of Supriya Lifescience IPO is ₹274.00 per share.
Metro Brands IPO | Supriya Lifescience IPO | |
---|---|---|
Face Value | ₹5 per share | ₹2 per share |
Issue Price (Lower) | ₹485.00 per share | ₹265.00 per share |
Issue Price (Upper) | ₹500.00 per share | ₹274.00 per share |
Issue Price (Final) | ₹500.00 per share | ₹274.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 30 shares | 54 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹295.00 Cr | up to ₹200.00 Cr |
OFS Issue Size | 2,14,50,100 shares | |
OFS Issue Size (Amount) | up to ₹1,072.51 Cr | up to ₹500.00 Cr |
Issue Size Total | ||
Issue Size Total (Amount) | up to ₹1,367.51 Cr | up to ₹700.00 Cr |
Metro Brands IPO opens on Dec 10, 2021, while Supriya Lifescience IPO opens on Dec 16, 2021. The closing date of Metro Brands IPO and Supriya Lifescience IPO is Dec 14, 2021, and Dec 20, 2021, respectively.
Metro Brands IPO | Supriya Lifescience IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Dec 10, 2021 | Dec 16, 2021 |
Issue Close | Dec 14, 2021 | Dec 20, 2021 |
Basis Of Allotment (Tentative) | Dec 17, 2021 | Dec 23, 2021 |
Initiation of Refunds (Tentative) | Dec 20, 2021 | Dec 24, 2021 |
Credit of Share (Tentative) | Dec 21, 2021 | Dec 27, 2021 |
Listing date (Tentative) | Dec 22, 2021 | Dec 28, 2021 |
Anchor Lockin End date 1 | Jan 16, 2022 | Jan 22, 2022 |
Anchor Lockin End date 2 | Mar 17, 2022 | Mar 23, 2022 |
Metro Brands IPO P/E ratio is , as compared to Supriya Lifescience IPO P/E ratio of .
Metro Brands IPO | Supriya Lifescience IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 84.02% | 99.98% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 74.27% | 68.24% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Metro Brands IPO retail investors (RII) are offered 95,72,535 shares while in Supriya Lifescience IPO retail investors are offered 95,72,535 shares. Qualified institutional buyers (QIB) are offered 54,70,020 shares in Metro Brands IPO and 79,24,527 shares in Supriya Lifescience IPO.
Metro Brands IPO | Supriya Lifescience IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 54,70,020 shares | 79,24,527 shares |
NII | 41,02,515 shares | 39,62,263 shares |
RII | 95,72,535 shares | 26,41,509 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 1,91,45,070 shares | 1,45,28,299 shares |
Metro Brands IPO subscribed 3.64x in total, whereas Supriya Lifescience IPO subscribed 71.51x.
Metro Brands IPO | Supriya Lifescience IPO | |
---|---|---|
QIB (times) | 8.49x | 31.83x |
NII (times) | 3.02x | 161.22x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 1.13x | 56.01x |
Employee (times) | ||
Other (times) | ||
Total (times) | 3.64x | 71.51x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|